RS Research

Company profile

RS Research company profile

RS Research is a clinical-stage biotechnology start-up developing novel smart nanomedicines with superior therapeutic index. The company has discovered a novel drug delivery platform which empowers its current development programs in various preclinical and clinical stages for targeted therapies. The proprietary drug delivery platform Sagitta® allows designing targeted drug candidates for different indications, which yields into development of RS Research's current portfolio as well as an outstanding co-development potential. RS Research has a GMP-certified production facility for clinical development and has been successfully conducting co-development projects with its international partners. The company's lead candidate RS-0139 is currently studied under the clinical Phase I in oncology patients.